Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 March, 2019 00:38 IST
Sun Pharma gets USFDA nod For generic Ganirelix Acetate injection
Source: IRIS | 03 Dec, 2018, 09.40AM
Comments  |  Post Comment

Sun Pharmaceutical Industries, today announced that Sun Pharma (Q,N,C,F)* has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Ganirelix Acetate Injection, 250 mcg/0.5 mL.

The generic version is therapeutic equivalent to Organon's Ganirelix Acetate Injection, 250 mcg/0.5 mL. As per IQVIA, Ganirelix Acetate Injection, 250 mcg/0.5 mL had annual sales of approximately USS 67 million in the US for the 12 months ended September 2018. The commercialization of this product in the US market is expected in Q4FY19. 

Shares of the company declined Rs 46.6, or 9.47%, to trade at Rs 445.70. The total volume of shares traded was 797,103 at the BSE (9.32 a.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer